John Devlin

Dr. Devlin’s research that has been supported by more than $5 million in federal and industry funding and resulted in more than 200 peer-reviewed publications focuses on the detection, prevention and treatment of delirium and disrupted sleep in the ICU and the pharmacoepidemiology of delirium in critically ill adults. In addition to his roles at Northeastern, he is a critical care pharmacist and Associate Scientist in the Division of Pulmonary and Critical Care Medicine at Brigham and Women’s Hospital and an Instructor of Medicine at Harvard Medical School, Boston, MA. He has mentored multiple ICU pharmacists through a long-standing Northeastern critical care fellowship/PhD program. Dr. Devlin chaired SCCM’s 2018 PADIS guidelines and served as panel member for ATS’s recent ICU sleep research task force. He currently serves as a NIDUS co-investigator; co-directing the dissemination core and its annual research bootcamp. He is a member of the editorial boards of Critical Care Medicine and Pharmacotherapy and is a past president of the American Delirium Society

Education:

• Post-doctoral research fellow, Henry Ford Hospital, Detroit, MI
• Practice Residency, London Health Sciences Center, London, CA
• Doctor of Pharmacy, University of Toronto
• Bachelors of Science in Pharmacy, University of Toronto

Specializations:

• Critical Care

Research Interests:

• Intensive Care, Delirium, Sedation, Sleep

Selected Honors and Awards:

• Master of Critical Care Medicine
  
• Society of Critical Care Medicine – 2020 Fellow
• American College of Clinical Pharmacy – 2005 Fellow